KOPRAN
|
KOPRAN Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹36 Cr | ₹82 Cr | ₹83 Cr | ₹29 Cr | ₹32 Cr |
Adjustment | ₹16 Cr | ₹14 Cr | ₹16 Cr | ₹22 Cr | ₹13 Cr |
Changes In working Capital | ₹-5.55 Cr | ₹-111 Cr | ₹-24 Cr | ₹-12 Cr | ₹-16 Cr |
Cash Flow after changes in Working Capital | ₹47 Cr | ₹-15 Cr | ₹76 Cr | ₹39 Cr | ₹29 Cr |
Cash Flow from Operating Activities | ₹34 Cr | ₹-33 Cr | ₹60 Cr | ₹31 Cr | ₹25 Cr |
Cash Flow from Investing Activities | ₹-13 Cr | ₹-84 Cr | ₹-25 Cr | ₹-13 Cr | ₹-25 Cr |
Cash Flow from Financing Activities | ₹-20 Cr | ₹123 Cr | ₹-35 Cr | ₹-18 Cr | ₹-0.58 Cr |
Net Cash Inflow / Outflow | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr | ₹0.42 Cr | ₹-0.03 Cr |
Opening Cash & Cash Equivalents | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr | ₹0.41 Cr | ₹0.44 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹7.40 Cr | ₹5.87 Cr | ₹0.94 Cr | ₹0.83 Cr | ₹0.41 Cr |
Compare Cashflow Statement of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,228.6 Cr | 1% | 1% | 75.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 1% |
1% |
75.7% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses